New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors-Reference-Cited by-同舟云学术

New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors

Published:2014-04-07 Issue:8 Volume:69 Page:2118-2122
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:Journal of Antimicrobial Chemotherapy

Author:

Malet I.,Gimferrer Arriaga L.,Artese A.,Costa G.,Parrotta L.,Alcaro S.,Delelis O.,Tmeizeh A.,Katlama C.,Valantin M.-A.,Ceccherini-Silberstein F.,Calvez V.,Marcelin A.-G.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Reference17 articles.

1. Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

2. Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo

3. Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors

4. Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro

5. Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicinal chemistry perspectives on the development of piperazine-containing HIV-1 inhibitors;Bioorganic & Medicinal Chemistry;2024-02

2. Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes;The Journal of Infectious Diseases;2024-01-11

3. Structural effects of HIV-1 subtype C integrase mutations on the activity of integrase strand transfer inhibitors in South African patients;Journal of Biomolecular Structure and Dynamics;2021-09-06

4. A systematic review of the genetic mechanisms of dolutegravir resistance;Journal of Antimicrobial Chemotherapy;2019-07-05

5. Consensus Integrase of a New HIV-1 Genetic Variant CRF63_02A1;Acta Naturae;2019-03-15